Cargando…

Advances in molecular characterization of myeloid proliferations associated with Down syndrome

Myeloid leukemia associated with Down syndrome (ML-DS) has a unique molecular landscape that differs from other subtypes of acute myeloid leukemia. ML-DS is often preceded by a myeloproliferative neoplastic condition called transient abnormal myelopoiesis (TAM) that disrupts megakaryocytic and eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jixia, Kalev-Zylinska, Maggie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399805/ https://www.ncbi.nlm.nih.gov/pubmed/36035173 http://dx.doi.org/10.3389/fgene.2022.891214

Ejemplares similares

Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development
por: Li, Jixia, et al.
Publicado: (2023)

Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
por: Immanuel, Tracey, et al.
Publicado: (2022)

New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease
por: Venegas-Zamora, Leslye, et al.
Publicado: (2022)

N-Methyl-D-Aspartate Receptors in Hematopoietic Cells: What Have We Learned?
por: Kalev-Zylinska, Maggie L., et al.
Publicado: (2020)

The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry
por: Varghese, Chris, et al.
Publicado: (2021)

Hearing impairment in murine model of Down syndrome
por: Chen, Guang-Di, et al.
Publicado: (2022)

Tiny Toes to Tau Tangles: Down's Syndrome and Its Association With Alzheimer's Disease
por: Puttagunta, Sri Madhurima, et al.
Publicado: (2022)

Molecular Characterization of the Highest Risk Adult Patients With Acute Myeloid Leukemia (AML) Through Multi-Omics Clustering
por: Nguyen, Trinh, et al.
Publicado: (2021)

Incidence of Down Syndrome by maternal age in Chinese population
por: Song, Yi, et al.
Publicado: (2022)

Unusual Findings in Down’s Syndrome: Hand Agenesis and Hypospadias
por: Kesrouani, Assaad, et al.
Publicado: (2022)

Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients
por: Gatua, Mercy, et al.
Publicado: (2022)

DNA Methylation Analysis of Ribosomal DNA in Adults With Down Syndrome
por: Ravaioli, Francesco, et al.
Publicado: (2022)

Treatment Modalities for Dementia in Down’s Syndrome: A Literature Review
por: Lamsal Lamichhane, Smriti, et al.
Publicado: (2022)

Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells
por: Mollo, Nunzia, et al.
Publicado: (2019)

N‐methyl‐d‐aspartate receptor mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines
por: Kamal, Tania, et al.
Publicado: (2017)

ORF8 and Health Complications of COVID-19 in Down Syndrome Patients
por: Bensussen, Antonio, et al.
Publicado: (2022)

Biphasic cell cycle defect causes impaired neurogenesis in down syndrome
por: Sharma, Vishi, et al.
Publicado: (2022)

Corrigendum: Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells
por: Mollo, Nunzia, et al.
Publicado: (2020)

Editorial: Down syndrome: Genetic and epigenetic influences on this multi-faceted condition
por: Ghosh, Sujay, et al.
Publicado: (2023)

Genome-Wide Association Analyses Identify Variants in IRF4 Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility
por: Wang, Junke, et al.
Publicado: (2021)

Down Syndrome Related Muscle Hypotonia: Association with COL6A3 Functional SNP rs2270669
por: Dey, Arpita, et al.
Publicado: (2013)

The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects
por: Coppedè, Fabio
Publicado: (2015)

Myeloid Leukemia of Down Syndrome
por: Kosmidou, Aikaterini, et al.
Publicado: (2023)

From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome
por: Watson, L. Ashley, et al.
Publicado: (2023)

Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New KCNJ6 and DSCR4 Transcript Isoforms
por: Antonaros, Francesca, et al.
Publicado: (2021)

Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019
por: Chen, Liyuan, et al.
Publicado: (2022)

Maternal LINE-1 DNA Methylation and Congenital Heart Defects in Down Syndrome
por: Babić Božović, Ivana, et al.
Publicado: (2019)

Prevalence and Treatment Outcome of Nasolacrimal Duct Obstruction in Saudi Children with Down Syndrome
por: Abdu, Lujain, et al.
Publicado: (2020)

Specificity: A Phenotypic Comparison of Communication-Relevant Domains Between Youth With Down Syndrome and Fragile X Syndrome
por: del Hoyo Soriano, Laura, et al.
Publicado: (2018)

Molecular Characterization of New FBXL4 Mutations in Patients With mtDNA Depletion Syndrome
por: Emperador, Sonia, et al.
Publicado: (2020)

Integrative Analysis Extracts a Core ceRNA Network of the Fetal Hippocampus With Down Syndrome
por: Wang, Shengran, et al.
Publicado: (2020)

FLT3 Mutations in Acute Myeloid Leukemia: Unraveling the Molecular Mechanisms and Implications for Targeted Therapies
por: Jalte, Meryem, et al.
Publicado: (2023)

Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression
por: De Rosa, Laura, et al.
Publicado: (2022)

Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2022)

Down-Klinefelter Syndrome (48,XXY,+21) in a Saudi Neonate: A Case Report and Literature Review
por: Alallah, Jubara, et al.
Publicado: (2022)

Ten Reasons Why People With Down Syndrome are Protected From the Development of Most Solid Tumors -A Review
por: Osuna-Marco, Marta Pilar, et al.
Publicado: (2021)

POLR2A Promotes the Proliferation of Gastric Cancer Cells by Advancing the Overall Cell Cycle Progression
por: Jiang, Qiuyu, et al.
Publicado: (2021)

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022)

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2
por: Gómez-Benito, M, et al.
Publicado: (2010)

Enhanced GIRK2 channel signaling in Down syndrome: A feasible role in the development of abnormal nascent neural circuits
por: Kleschevnikov, Alexander M.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_epket2hjc6pj6lqk42feqdk85o